Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
You've been in a bit longer than me but I am holding for the long term too.
Good research - although the Hardman research is from last May. I assume you are still interested in PIM despite some of your cautious sentiment on this BB? The research shows there are several potential game changers in there (Alathea for example) and points to break even in 2013.
20th Feb 2012, 10:17 am by Giles Gwinnett Shares in Plant Impact (LON:PIM) went up after it revealed changes in its agreement with Arysta over BugOil, an insect control product, which the company says will improve its cash outlook. The geographic scope of Arysta LifeScience Corporation's exclusive licence of the product has been narrowed and the repayment date of a £750,000 development loan from Arysta which had been due on February 22 this year has now been extended to May 31 in 2013. The firm said it believed the amendments "markedly" improved its financial position and cash flow outlook. "The extension of the Arysta loan provides the company with additional time to achieve regulatory milestones as well as the ability - in the event regulatory milestones are not achieved - to repay the Arysta loan from internal cash generated from the growth in revenues of the company's nutritional product range," it said. The original agreement in 2009 gave Arysta an exclusive worldwide licence to manufacture and sell BugOil, which is based on plant extracts.
Info not meant to be misleading - I was drawing attention to the fact that Bug Oil is only one of the technologies they have been working on. I should have made that clearer.
David Dent considers Plant Impact, which is listed on the AIM market of the London Stock Exchange, to be foremost among the companies pursuing what he describes as the “third way” – a combination of ‘green chemistry’ and intelligent design solutions. One of the products developed by David Marks, Chief Technical Officer at Plant Impact, Bug Oil®, is described by Dent as “a brilliantly simple product based on three essential oils working in synergy to provide a very effective preventative and curative pesticide”. Plant Impact recently signed a deal with DVA Agro GmbH for distribution of BugOil® as Bionic™, specifically for ornamental rose production in Tanzania. Other innovative products include InCa, a plant supplement which improves crop product quality by combining a calcium salt with an auxin mimic to ensure the calcium arrives at the part of the plant which needs it most. InCa offers improved fruit quality, longer shelf life and resistance to climate stress. Plant Impact has signed a five year agreement with US based Miller Chemical & Fertilizer Corporation for the distribution of three products including InCa. Field trials on InCa, in conjunction with Miller, have demonstrated significant advantages in fruit crops, notably apples and pears. A Miller field trial, the first field trial conducted using InCa on arable crops, demonstrated a reduction in the negative effects of drought stress on soya crop by increasing the yield by 17.5%, from 2.69 tonnes/hectare to 3.16 tonnes/hectare. According to Dent, Plant Impact’s products “owe their success more to understanding the market need and designing products from basic principles to meet that need as opposed to seeking a magic bullet molecule”.
No, I believe it will be distribution news. Mu understanding is that the Arysta connection will underpin this and that Bug Oil will indeed be a viable product. I think the main reason the market did not react is that the last RNS was only part of the jigsaw.
Contradicting your argument Seand. Not that it means you are wrong but I think you arr far too pessimistic. I wonder why? This share has fallen as far as it has to fall.
So many shares in my PF to keep an eye on at the moment. Just been dipping in here. Did not expect this movement so soon.
and how I have been wishing I had sold on the Arysta spike last year. However, things are really falling in place nd this will be back on the radar for a lot of investors. Could be some very good news soon. Se riddler's post for basis of the optimism
Hope it will be sustained. Been quiet in here of late.
I have spoken to a friend in Northern Ireland (he's a journalist with Belfast telegraph) who has visited the site of the plant. It is very close to opening. I would expect an RNS next month. Also, this offers long term hope on the Enfield site: Once fully commissioned, the plant is estimated to see revenues of £13 million and an EBITDA of £8 million per annum.
A good slice of placing. I see this as a very encouraging sign, With the new factory on stream by Q2 it will double the revenue of the company.
Vincent, I thinbk you have stumbled on an important piece of the jigsaw. The SP has started to meove north again as well.
But will it make a difference?
Look at what Arysta paid for the share - 45p. That should be achieved this year on the back of the latest RNS.
Been regretting not selling on spike when Arysta bought in but today's RNS vindicates the long wait. GLA.
and prepapare for take-off. I did not expect news today so it is a very pleasant surprise. This is a very good prospect and I am delighted to be in here - albeit after the big jump in November.
Great idea for very short sighted. Look at the value us this company - as RefineryQS said, this should have been sitting at 2-3p before the news. Now I t should be at 4p. I would be topping up if I had more cash to do it but I'll be holding what I have. Anyone with spare cash should be piling it in here.
This share has been sooo undervalued since Japanese Tsunami. Look at where the SP was prior to that for true valuation - 4p is a good target for this Q.
Was waiting for news in Q2 for this but seems something is happening already.